SPARTAN Group

Spondyloarthritis Research and Treatment Network

  • Become a SPARTAN Member
  • Donate
  • Contact Us
  • Log In
  • Home
  • About Us
    • About Spondyloarthritis
    • About SPARTAN
    • Leadership
    • Committees
    • Awards
    • Bylaws
  • Membership
    • Become a SPARTAN Member
    • Corporate Membership
    • Member Directory
  • Annual Meeting
    • SPARTAN Annual Meeting
    • Virtual Meeting – Corporate Members
    • Trainee Symposium
    • 2020 Trainee Abstracts
  • Projects
    • CLASSIC Study
    • SPARTAN Overhead Policy
  • Grants
    • Fellowship Grants for Pilot Projects
    • Seed Grants for Junior Faculty
  • Education
    • SpA Sessions at ACR Convergence 2020
    • Publications
      • SPARTAN Newsletter Archives
      • Treatment Guidelines
    • What are the classification criteria for axSpA/AS?
    • Which outcome measures are typically used in axial SpA/AS trials?
  • Members
    • Log Out

About Spondyloarthritis

About SpondyloarthritisSpondyloarthritis is an inflammatory arthritis that affects the axial, or central, skeleton. The back pain of spondyloarthritis tends to improve with activity and worsen with rest. It shares a genetic overlap with skin psoriasis, inflammatory bowel disease, and inflammatory eye disease. As a result, individuals with spondyloarthritis are more likely to have these conditions, as well as arthritis of smaller joints and irritations of tendons and connective tissue (such as plantar fasciitis).

The disease typically begins before the age of 40 and has a hereditary component, meaning that spondyloarthritis can afflict multiple family members. The diagnosis is made by considering a person’s medical history, the pattern of their symptoms, x-rays and/or magnetic resonance imaging. Blood markers of inflammation and a genetic test called HLA-B27 may help clarify the diagnosis, though these tests are imprecise and as a result do not confirm the diagnosis.

 

Copyright © 2021 SPARTAN · Log in